Editorial: Vasodilator therapy of myocardial infarction.
D001794:Blood Pressure; D002302:Cardiac Output; D005292:Ferricyanides / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D009569:Nitric Oxide / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D005292:Ferricyanides; D014665:Vasodilator Agents; D009569:Nitric Oxide; D005996:Nitroglycerin; D010646:Phentolamine